The placebo effect: From concepts to genes
详细信息 查看全文
- 作者：B. Colagiuria ; L.A. Schenkb ; M.D. Kesslerc ; S.G. Dorseyd ; e ; f ; L. Collocad ; e ; f ; colloca@son.umaryland.edu" class="auth_mail" title="E-mail the corresponding author
- 关键词：ACC ; anterior cingulate cortex ; BDNF ; brain-derived neurotrophic factor ; CCK ; cholecystokinin ; COMT ; catechol-O-methyltransferase ; DBH ; dopamine beta-hydroxylase ; DLPFC ; dorsolateral prefrontal cortex ; DRD3 ; dopamine receptor D3 ; FA ; fractional anisotrophy ; FAAH ; fatty acid amide hydrolase ; fMRI ; functional magnetic resonance imaging ; GMD ; gray matter density ; HTR2 ; 5-hydroxytryptamine (serotonin) receptor 2A ; IBS ; irritable bowel syndrome ; MAF ; Minor Allele Frequency ; MAO-A ; monoamine oxidase A
- 刊名：Neuroscience
- 出版年：2015
- 出版时间：29 October 2015
- 年：2015
- 卷：307
- 期：Complete
- 页码：171-190
- 全文大小：1562 K
文摘
- •
Verbal, conditioned and social cues create expectancy driving the placebo effect.
- •
Neuroimaging studies implicate key brain mechanisms underlying the placebo effect.
- •
The placebo effect involves the release of opioids, dopamine, and cannabinoids.
- •
Oxytocin and vasopressin receptor agonists enhance the placebo effect.
- •
Some genetic variants appear promising for predicting placebo responsiveness.